April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Functional Evidence for Purinoceptor Expression in RGC-5 Cells
Author Affiliations & Notes
  • P. Sidaway
    School of Chemistry and Pharmacy, University of East Anglia, Norwich, United Kingdom
  • N. Niyadurupola
    Department of Ophthalmology, Norfolk & Norwich University Hospital, Norwich, United Kingdom
  • D. C. Broadway
    Department of Ophthalmology, Norfolk & Norwich University Hospital, Norwich, United Kingdom
  • J. Sanderson
    School of Chemistry and Pharmacy, University of East Anglia, Norwich, United Kingdom
  • Footnotes
    Commercial Relationships  P. Sidaway, None; N. Niyadurupola, None; D.C. Broadway, None; J. Sanderson, None.
  • Footnotes
    Support  The Humane Research Trust and The Norwich Glaucoma Research Fund
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 82. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Sidaway, N. Niyadurupola, D. C. Broadway, J. Sanderson; Functional Evidence for Purinoceptor Expression in RGC-5 Cells. Invest. Ophthalmol. Vis. Sci. 2009;50(13):82.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : There is known to be a release of purines from the posterior of the eye caused by a range of pathological insults. Responses of retinal ganglion cells to extracellular purines may be implicated in the pathogenesis of glaucoma.

Methods: : A rat retinal ganglion cell line (RGC-5) was routinely cultured in DMEM, supplemented with 10% FCS. Prior to use, RGC-5 cells were differentiated by exposure to 1µM staurosporine (SS) for 24 hours. Cells were loaded with the ratiometric dye Fura-2 and used for calcium imaging up to 2 days post differentiation.

Results: : The purinoceptor agonists ATP, UTP, BzATP, ADP and UDP stimulate a concentration-dependant increase in intracellular calcium (Ca2+i) in RGC-5 cells. ATP and UTP had the greater affinity for RGC-5 purinoceptors and were equipotent (EC50~ 30µM). This compares to EC50s for BzATP, ADP and UDP of ~80µM, ~100µM and ~180µM respectively. ATP, UTP, and BzATP gave the highest maximal responses. Removal of extracellular calcium had no effect on ATP, UTP, BzATP, ADP or UDP-mediated calcium increase. ATP and UTP mediated responses were both inhibited by the P2 antagonists PPADS and suramin to a similar extent, and were also proven to be thapsigargin sensitive.

Conclusions: : Differentiated RGC-5 cells can respond to a range of different purinoceptor agonists. Functional data suggests that these agonists are signaling through P2Y receptors. There was no evidence for activation of P2X receptors using these techniques. The equipotent data suggest that P2Y2 receptors are the dominant subtype.

Keywords: ganglion cells • receptors: pharmacology/physiology • calcium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×